Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Cyclooxygenase-2: potential role in regulation of drug efflux and multidrug resistance phenotype.

Current pharmaceutical design - 1 Jan 2004

Sorokin A

Abstract excerpt

Multidrug resistance (MDR) of cancer cells to cytostatic agents is the major obstacle for the succesfull chemotherapy. One of the causes of the development of cellular resistance to a wide variety of drugs is the elevated expression of membrane transporter proteins such as members of ATP binding...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to ATP-Binding Cassette Transporters
Share to Cyclooxygenase 2
Share to Cyclooxygenase 2 Inhibitors

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Cyclooxygenase Inhibitors

Share to Drug Resistance, Multiple

Share to Inflammation

Share to Isoenzymes

Share to Prostaglandin-Endoperoxide Synthases

Source

Identifiers

PMID: 14965327
DOI: 10.2174/1381612043453117

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026. Prepared record publication-14965327-2026-09-01.1. Manifest publication-graph-cohort-2026-09-01.1.

Source receipt: PubMed via Helena Literature Corpus, retrieved 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Cyclooxygenase-2: potential role in regulation of drug efflux and multidrug resistance phenotype.PMID 14965327Read ↗

[Cyclooxygenase 2 and carcinogenesis].Semantic proximity Read ↗

Cyclooxygenase-2: a novel target for cancer chemotherapy?Semantic proximity Read ↗

Cyclooxygenase‐2 modulates cellular growth and promotes tumorigenesisSemantic proximity Read ↗

Cyclooxygenase 2-Regulated Genes an Alternative Avenue to the Development of New Therapeutic Drugs for Colorectal CancerSemantic proximity Read ↗

Cyclooxygenase-2 inhibitors reverse chemoresistance phenotype in medullary thyroid carcinoma by a permeability glycoprotein-mediated mechanism.Semantic proximity Read ↗

High expression of COX-2 and MDR1 implicate resistance development to imatinib therapy in chronic myeloid leukemia patientsSemantic proximity Read ↗

Targeting cyclooxygenase‐2 for prevention and therapy of colorectal cancerSemantic proximity Read ↗

Cyclooxygenase-2 expression in human colon cancer cells increases metastatic potentialSemantic proximity Read ↗

The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line.Semantic proximity Read ↗

YAP transcriptionally regulates COX-2 expression and GCCSysm-4 (G-4), a dual YAP/COX-2 inhibitor, overcomes drug resistance in colorectal cancerSemantic proximity Read ↗

Association between Cyclooxygenase-2 and Indoleamine 2,3-Dioxygenase Expression in Breast Cancer Patients from Pakistan.Semantic proximity Read ↗

Cyclooxygenase-2 inhibitors prevent the development of chemoresistance phenotype in a breast cancer cell line by inhibiting glycoprotein p-170 expression.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.